Intel
INTC
Broadcom
AVGO
Alibaba
BABA
NVIDIA
NVDA
Micron Technology
MU
US Stock MarketDetailed Quotes
BCAX Bicara Therapeutics
- 12.110
- +0.230+1.94%
Close Jan 17 16:00 ET
- 11.950
- -0.160-1.32%
Pre 06:05 ET
658.97MMarket Cap-11.08P/E (TTM)
12.230High11.560Low234.94KVolume12.010Open11.880Pre Close2.79MTurnover1.34%Turnover RatioLossP/E (Static)54.42MShares28.09052wk High1.29P/B211.93MFloat Cap11.55852wk Low--Dividend TTM17.50MShs Float28.090Historical High--Div YieldTTM5.64%Amplitude11.558Historical Low11.893Avg Price1Lot Size
Bicara Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expense | 116.45%20.63M | 5.93%39.89M | 13.69M | 9.53M | 37.66M |
| Selling and administrative expenses | 83.87%4.76M | 46.15%9.27M | --3.13M | --2.59M | --6.34M |
| -General and administrative expense | 83.87%4.76M | 46.15%9.27M | --3.13M | --2.59M | --6.34M |
| Research and development costs | 128.62%15.86M | -2.22%30.62M | --10.56M | --6.94M | --31.31M |
| Operating profit | -116.45%-20.63M | -5.93%-39.89M | -13.69M | -9.53M | -37.66M |
| Net non-operating interest income expense | 24,107.69%3.15M | 1,316.67%1.31M | 1.3M | 13K | -108K |
| Non-operating interest income | 24,107.69%3.15M | 32,750.00%1.31M | --1.3M | --13K | --4K |
| Non-operating interest expense | ---- | --0 | ---- | ---- | --112K |
| Other net income (expense) | -16,656.25%-13.41M | -49K | -13.33M | -80K | |
| Other non- operating income (expenses) | ---- | -16,656.25%-13.41M | ---49K | ---13.33M | ---80K |
| Income before tax | 23.48%-17.48M | -37.35%-51.98M | -12.44M | -22.85M | -37.84M |
| Income tax | 0 | 400.00%5K | 5K | 0 | 1K |
| Net income | 23.48%-17.48M | -37.36%-51.99M | -12.44M | -22.85M | -37.85M |
| Net income continuous Operations | 23.48%-17.48M | -37.36%-51.99M | ---12.44M | ---22.85M | ---37.85M |
| Minority interest income | |||||
| Net income attributable to the parent company | 23.48%-17.48M | -37.36%-51.99M | -12.44M | -22.85M | -37.85M |
| Preferred stock dividends | |||||
| Other preferred stock dividends | |||||
| Net income attributable to common stockholders | 23.48%-17.48M | -37.36%-51.99M | -12.44M | -22.85M | -37.85M |
| Basic earnings per share | -138.02%-1.6 | -37.49%-3.37 | -0.366 | -0.6722 | -2.451 |
| Diluted earnings per share | -138.02%-1.6 | -37.49%-3.37 | -0.366 | -0.6722 | -2.451 |
| Dividend per share | |||||
| Currency Unit | USD | USD | USD | USD | USD |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
